JPMorgan analyst Casey Woodring raised the firm’s price target on Thermo Fisher (TMO) to $650 from $600 and keeps an Overweight rating on the shares as part of a Q3 preview for the life science tools group. The firm sees tools companies taking a more conservative stance on 2026 pending more evidence of order improvement. JPMorgan lowered 2026 numbers for several tools companies into the quarter.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target raised to $575 from $525 at Rothschild & Co Redburn
- Thermo Fisher put volume heavy and directionally bearish
- Thermo Fisher Issues $2.5 Billion in Senior Notes
- Thermo Fisher price target raised to $585 from $550 at Barclays
- Early notable gainers among liquid option names on October 1st